Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The skincare business is expected to regain momentum in the second half of the year, while the medical aesthetics segment is building a new growth curve [1] - The company reported a revenue of 5.52 billion yuan for 2025, a slight decrease of 0.4% year-on-year, and a net profit attributable to shareholders of 1.91 billion yuan, down 7.2% year-on-year [3][4] - The first half of 2025 saw a revenue of 3.11 billion yuan, up 22.5% year-on-year, while the second half experienced a decline of 19.8% [3][4] Revenue Performance - The company's professional skincare products generated revenue of 5.50 billion yuan in 2025, with functional skincare products accounting for 4.34 billion yuan, a year-on-year increase of 0.8% [4] - The revenue from the medical dressing segment was 1.16 billion yuan, down 4.8% year-on-year [4] - The company's main brand, 可复美, generated 4.47 billion yuan in revenue, a decrease of 1.6% year-on-year, while the 可丽金 brand saw a revenue increase of 9.2% to 0.92 billion yuan [4] Product and Brand Development - In 2025, the company launched the 可复美胶原棒 2.0 and plans to introduce significant new products in 2026 [5] - The company is also focusing on expanding its product matrix with new launches in various series, which is expected to optimize revenue structure [7] Financial Metrics - The company's gross margin decreased by 1.8 percentage points to 80.3% in 2025, attributed to changes in product mix and a decline in high-margin medical dressing revenue [6] - The sales, management, and R&D expense ratios were 37.3%, 3.1%, and 1.6% respectively, with an increase in sales expense ratio due to heightened brand investment [6] Future Outlook - The company is expected to return to a growth trajectory through continuous product innovation and expansion in the medical aesthetics sector [7] - The net profit forecasts for 2026 and 2027 have been adjusted to 2.01 billion yuan and 2.37 billion yuan, respectively, reflecting a downward revision of 42% and 47% [7]

Core Viewpoint - The beauty industry is undergoing a significant shift, with consumers increasingly focusing on holistic experiences and the values represented by brands, rather than just product efficacy or singular concepts [2][4][27]. Group 1: Brand Theme and Strategy - In 2026, the brand established the annual theme "Love," aiming to resonate with contemporary women's multifaceted identities and lifestyles, emphasizing self-exploration and emotional fulfillment [4][5]. - The collaboration with spokesperson Jin Jing and the launch of a new thematic TVC reflect a natural evolution from the previous "self-appreciation" narrative to a broader exploration of the connection between skincare and lifestyle [2][5][24]. Group 2: Thematic Narrative in TVC - The TVC narrative unfolds across three real-life scenarios: workplace focus, solitude, and social connection, with the core imagery of "upward high-five" symbolizing both skin vitality and emotional growth [5][10][12]. - Each scenario emphasizes that every moment can serve as a pivot for upward growth, linking skincare to self-affirmation and emotional well-being [12][28]. Group 3: Professional and Scientific Backing - The brand's parent company, Juzi Biotechnology, holds multiple Class III medical device registrations, indicating high technical barriers and robust research capabilities, which support the anti-aging efficacy of its products [15][27]. - This scientific foundation reinforces the brand's narrative of "upward" not just as an emotional expression but as a concept backed by research and technology [15][33]. Group 4: Consumer Engagement and Cultural Resonance - The brand's approach to "Love" reflects a shift towards valuing the process of self-care and emotional well-being, rather than merely focusing on results [27][28]. - Collaborations with platforms like Douyin and Xiaohongshu further embed the theme of "Love" into everyday narratives, emphasizing that love exists in ordinary moments rather than grand gestures [24][26]. Group 5: Brand Evolution and Market Positioning - The transition from "self-appreciation" to "Love" illustrates the brand's ongoing narrative centered around human experiences, moving from product efficacy to a deeper connection with consumers' emotional states [30][33]. - As the beauty industry shifts towards a balance of technological strength and value expression, the brand aims to be a companion in consumers' journeys of self-discovery and affirmation [27][34].

Investment Rating - The report initiates coverage with an OUTPERFORM rating for Giant Biogene, with a target price of HK$43.60, indicating a potential upside of 22.0% from the current price of HK$35.74 [1][2][7]. Core Insights - The report expresses a long-term positive outlook on the recombinant collagen sector, highlighting its advantages in safety, efficacy, and sustainability, which are seen as fundamental drivers for industry growth [4][34]. - Giant Biogene has established itself as a leader in the recombinant collagen market, with a strategic shift towards brand development in 2026 [9][30]. Financial Summary - Revenue projections for 2025, 2026, and 2027 are estimated at RMB 54.9 billion, RMB 59.9 billion, and RMB 66.9 billion, respectively, with expected growth rates of -0.9%, 9.1%, and 11.8% [7][32]. - Net profit forecasts for the same years are RMB 18.8 billion, RMB 20.0 billion, and RMB 22.1 billion, with growth rates of -9.0%, 6.6%, and 10.5% [7][32]. - The gross profit margin is expected to remain stable at approximately 80.5% in 2025, declining slightly to 79.2% by 2027 [7][32]. Brand and Product Strategy - Giant Biogene operates eight brands, with the core brands being Kefu Mei and Keli Jin, which contribute over 95% of the company's revenue [5][11][13]. - The company plans to launch a medical device and five skincare series in 2026, alongside a brand revamp for Keli Jin [6][30][31]. - The focus will be on expanding both online and offline channels, with plans to increase the number of physical stores and enhance partnerships with high-potential retailers [31][32]. Market Position and Challenges - The company faces short-term challenges due to discussions around the content and testing methods of recombinant collagen, which have impacted sales, particularly for the Kefu Mei brand [18][20][25]. - Despite these challenges, the company is adjusting its strategies, including enhancing online marketing and product offerings to stabilize and grow its market presence [25][29][30].

Core Viewpoint - The 2025 China Fragrance, Flavor, and Cosmetics Industry Annual Conference and Boutique Expo (2025 CAME) will be held from September 25 to 27, 2025, at the Nanjing Yangtze River International Conference Center, providing opportunities for industry leaders to engage and explore high-value business collaborations [3]. Group 1: Event Details - The event will feature the latest trends in the fragrance and cosmetics market, showcasing innovative products across the entire industry chain [3]. - Attendees will have the chance to interact with decision-makers and technical experts from leading companies in the industry [3]. - Special activities will include on-site exhibitions and opportunities to receive gifts by visiting designated booths [3]. Group 2: Gift Distribution - Various brands will distribute gifts at their respective booths during the event, with specific quantities and products listed for each brand [4][7][8][11][14][17][20][23][26][28][30][33][34][36][38][42]. - For example, Shanghai Fenghua will distribute 300 travel-sized products, while Guangzhou Marubi will offer 200 samples of their skincare products [7][8]. - The distribution will occur from September 25 to 27, with some brands having specific time slots for gift distribution [18][23][26].

Investment Rating - The report maintains a "Buy" rating for the company [4][7] Core Insights - The company achieved a revenue of 3.113 billion yuan in H1 2025, representing a year-on-year growth of 22.5%, and a net profit attributable to the parent company of 1.182 billion yuan, up 20.2% year-on-year [1] - The gross margin for H1 2025 was 81.68%, a slight decrease of 0.72 percentage points year-on-year, while the net margin was 37.99%, down 0.61 percentage points year-on-year [1] - The sales expense ratio improved by 1 percentage point year-on-year to 34.01%, while the management expense ratio increased by 0.07 percentage points to 2.65% [1] Revenue and Profit Growth - The company's brand "可复美" generated revenue of 2.54 billion yuan in H1 2025, with a year-on-year increase of 22.7% [2] - The "可丽金" brand achieved revenue of 500 million yuan, reflecting a growth of 26.9% year-on-year [2] Channel Performance - Direct sales channels contributed 2.325 billion yuan in revenue, accounting for 74.7% of total revenue, with DTC channels generating 1.816 billion yuan [3] - The company has expanded its offline presence, covering approximately 1,700 public hospitals and 3,000 private hospitals and clinics, along with over 130,000 pharmacy stores [3] Financial Forecast - The company is projected to achieve net profits of 2.505 billion yuan, 3.102 billion yuan, and 3.732 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 21, 17, and 14 [4][6]

Core Viewpoint - The article emphasizes the importance of the "self-care" concept in the skincare industry, highlighting how brands like Keli Jin are redefining anti-aging narratives by integrating cultural philosophies and emotional connections into their products and experiences [4][10][22]. Group 1: Brand Activities and Philosophy - Keli Jin's event "My 'Reorganization' Energy" in Chengdu reflects a shift towards creating a gentle space for urban dwellers, focusing on self-awareness and emotional needs through skincare [2][4]. - The brand utilizes Eastern wellness philosophies, such as "regulating energy, following trends, and maintaining harmony," to connect skincare with personal well-being [2][7]. - The event featured activities like morning exercises and DIY scent bags, which engage multiple senses and promote a holistic approach to skincare [6][8]. Group 2: Emotional Connection and Consumer Engagement - The concept of "self-care" has evolved into a crucial channel for brands to establish deeper relationships with younger consumers, who seek products that resonate with their lifestyles and emotional needs [4][10]. - Keli Jin aims to transition from a focus on product functionality to building emotional connections, making "self-care" a core element of its brand identity [4][10][12]. Group 3: Technological Integration and Product Development - Keli Jin leverages over 20 years of research in recombinant collagen technology, holding 167 patents and applications, positioning itself as a leader in this field [12][22]. - The brand's core ingredient, C5HA recombinant collagen, is scientifically formulated to enhance skin absorption and promote collagen production, addressing both efficacy and consumer trust [12][14]. - Keli Jin's product matrix includes a range of items designed for both morning and night use, catering to the growing demand for "time-specific care" and "certain efficacy" among consumers [16][18]. Group 4: Market Trends and Brand Strategy - The skincare industry is witnessing a structural shift where emotional resonance and understanding consumer needs are becoming as important as product efficacy [19][22]. - Keli Jin's dual strategy of combining "soft narrative" with "hard technology" allows it to build a brand model that is both scientifically grounded and emotionally engaging [22][30]. - The brand's approach to anti-aging is reframed from a battle against time to a gentle reorganization of one's state, aligning with modern consumer desires for self-acceptance and emotional well-being [29][30].